Medical Care

Global Melanoma Cancer Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Melanoma Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melanoma Cancer.
The Melanoma Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Melanoma Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melanoma Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
Segment by Type
Non-invasive melanoma
Invasive melanoma
Segment by Application
Hospitals
Cancer Research Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melanoma Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-invasive melanoma
1.2.3 Invasive melanoma
1.3 Market by Application
1.3.1 Global Melanoma Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Cancer Market Perspective (2020-2031)
2.2 Global Melanoma Cancer Growth Trends by Region
2.2.1 Global Melanoma Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Melanoma Cancer Historic Market Size by Region (2020-2025)
2.2.3 Melanoma Cancer Forecasted Market Size by Region (2026-2031)
2.3 Melanoma Cancer Market Dynamics
2.3.1 Melanoma Cancer Industry Trends
2.3.2 Melanoma Cancer Market Drivers
2.3.3 Melanoma Cancer Market Challenges
2.3.4 Melanoma Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Cancer Players by Revenue
3.1.1 Global Top Melanoma Cancer Players by Revenue (2020-2025)
3.1.2 Global Melanoma Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Melanoma Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Melanoma Cancer Revenue
3.4 Global Melanoma Cancer Market Concentration Ratio
3.4.1 Global Melanoma Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Revenue in 2024
3.5 Global Key Players of Melanoma Cancer Head office and Area Served
3.6 Global Key Players of Melanoma Cancer, Product and Application
3.7 Global Key Players of Melanoma Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Cancer Breakdown Data by Type
4.1 Global Melanoma Cancer Historic Market Size by Type (2020-2025)
4.2 Global Melanoma Cancer Forecasted Market Size by Type (2026-2031)
5 Melanoma Cancer Breakdown Data by Application
5.1 Global Melanoma Cancer Historic Market Size by Application (2020-2025)
5.2 Global Melanoma Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Melanoma Cancer Market Size (2020-2031)
6.2 North America Melanoma Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Melanoma Cancer Market Size by Country (2020-2025)
6.4 North America Melanoma Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Melanoma Cancer Market Size (2020-2031)
7.2 Europe Melanoma Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Melanoma Cancer Market Size by Country (2020-2025)
7.4 Europe Melanoma Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Melanoma Cancer Market Size (2020-2031)
8.2 Asia-Pacific Melanoma Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Melanoma Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Melanoma Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Melanoma Cancer Market Size (2020-2031)
9.2 Latin America Melanoma Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Melanoma Cancer Market Size by Country (2020-2025)
9.4 Latin America Melanoma Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melanoma Cancer Market Size (2020-2031)
10.2 Middle East & Africa Melanoma Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Melanoma Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Melanoma Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Sciences
11.1.1 AB Sciences Company Details
11.1.2 AB Sciences Business Overview
11.1.3 AB Sciences Melanoma Cancer Introduction
11.1.4 AB Sciences Revenue in Melanoma Cancer Business (2020-2025)
11.1.5 AB Sciences Recent Development
11.2 Incyte
11.2.1 Incyte Company Details
11.2.2 Incyte Business Overview
11.2.3 Incyte Melanoma Cancer Introduction
11.2.4 Incyte Revenue in Melanoma Cancer Business (2020-2025)
11.2.5 Incyte Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Melanoma Cancer Introduction
11.3.4 Merck Revenue in Melanoma Cancer Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Melanoma Cancer Introduction
11.4.4 Novartis Revenue in Melanoma Cancer Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Pierre Fabre
11.5.1 Pierre Fabre Company Details
11.5.2 Pierre Fabre Business Overview
11.5.3 Pierre Fabre Melanoma Cancer Introduction
11.5.4 Pierre Fabre Revenue in Melanoma Cancer Business (2020-2025)
11.5.5 Pierre Fabre Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Melanoma Cancer Introduction
11.6.4 Amgen Revenue in Melanoma Cancer Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Melanoma Cancer Introduction
11.7.4 AstraZeneca Revenue in Melanoma Cancer Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Melanoma Cancer Introduction
11.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2020-2025)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Melanoma Cancer Introduction
11.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Business (2020-2025)
11.9.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Melanoma Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-invasive melanoma
Table 3. Key Players of Invasive melanoma
Table 4. Global Melanoma Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Melanoma Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Melanoma Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Melanoma Cancer Market Share by Region (2020-2025)
Table 8. Global Melanoma Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Melanoma Cancer Market Share by Region (2026-2031)
Table 10. Melanoma Cancer Market Trends
Table 11. Melanoma Cancer Market Drivers
Table 12. Melanoma Cancer Market Challenges
Table 13. Melanoma Cancer Market Restraints
Table 14. Global Melanoma Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Melanoma Cancer Market Share by Players (2020-2025)
Table 16. Global Top Melanoma Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Cancer as of 2024)
Table 17. Ranking of Global Top Melanoma Cancer Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Melanoma Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Melanoma Cancer, Headquarters and Area Served
Table 20. Global Key Players of Melanoma Cancer, Product and Application
Table 21. Global Key Players of Melanoma Cancer, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Melanoma Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Melanoma Cancer Revenue Market Share by Type (2020-2025)
Table 25. Global Melanoma Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Melanoma Cancer Revenue Market Share by Type (2026-2031)
Table 27. Global Melanoma Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Melanoma Cancer Revenue Market Share by Application (2020-2025)
Table 29. Global Melanoma Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Melanoma Cancer Revenue Market Share by Application (2026-2031)
Table 31. North America Melanoma Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Melanoma Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Melanoma Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Melanoma Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Melanoma Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Melanoma Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Melanoma Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Melanoma Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Melanoma Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Melanoma Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Melanoma Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Melanoma Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Melanoma Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Melanoma Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Melanoma Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 46. AB Sciences Company Details
Table 47. AB Sciences Business Overview
Table 48. AB Sciences Melanoma Cancer Product
Table 49. AB Sciences Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 50. AB Sciences Recent Development
Table 51. Incyte Company Details
Table 52. Incyte Business Overview
Table 53. Incyte Melanoma Cancer Product
Table 54. Incyte Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 55. Incyte Recent Development
Table 56. Merck Company Details
Table 57. Merck Business Overview
Table 58. Merck Melanoma Cancer Product
Table 59. Merck Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Melanoma Cancer Product
Table 64. Novartis Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pierre Fabre Company Details
Table 67. Pierre Fabre Business Overview
Table 68. Pierre Fabre Melanoma Cancer Product
Table 69. Pierre Fabre Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 70. Pierre Fabre Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Melanoma Cancer Product
Table 74. Amgen Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Melanoma Cancer Product
Table 79. AstraZeneca Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Melanoma Cancer Product
Table 84. Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Daiichi Sankyo Company Details
Table 87. Daiichi Sankyo Business Overview
Table 88. Daiichi Sankyo Melanoma Cancer Product
Table 89. Daiichi Sankyo Revenue in Melanoma Cancer Business (2020-2025) & (US$ Million)
Table 90. Daiichi Sankyo Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report


List of Figures
Figure 1. Melanoma Cancer Picture
Figure 2. Global Melanoma Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Melanoma Cancer Market Share by Type: 2024 VS 2031
Figure 4. Non-invasive melanoma Features
Figure 5. Invasive melanoma Features
Figure 6. Global Melanoma Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Melanoma Cancer Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Melanoma Cancer Report Years Considered
Figure 11. Global Melanoma Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Melanoma Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Melanoma Cancer Market Share by Region: 2024 VS 2031
Figure 14. Global Melanoma Cancer Market Share by Players in 2024
Figure 15. Global Top Melanoma Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Cancer as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Melanoma Cancer Revenue in 2024
Figure 17. North America Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Melanoma Cancer Market Share by Country (2020-2031)
Figure 19. United States Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Melanoma Cancer Market Share by Country (2020-2031)
Figure 23. Germany Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Melanoma Cancer Market Share by Region (2020-2031)
Figure 31. China Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Melanoma Cancer Market Share by Country (2020-2031)
Figure 39. Mexico Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Melanoma Cancer Market Share by Country (2020-2031)
Figure 43. Turkey Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Melanoma Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. AB Sciences Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 47. Incyte Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 49. Novartis Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 50. Pierre Fabre Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 51. Amgen Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 52. AstraZeneca Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 54. Daiichi Sankyo Revenue Growth Rate in Melanoma Cancer Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies